C

Castle Biosciences
D

CSTL

29.520
USD
-0.29
(-0.97%)
Market Closed
Volume
0
EPS
0
Div Yield
-
P/E
141
Market Cap
826,775,526
OverviewSignalsIdeasNews
Related Instruments
    CL
    CL
    2.150
    (2.35%)
    93.600 USD
    C
    CLX
    1.930
    (1.16%)
    167.730 USD
    C
    CPB
    -1.285
    (-2.89%)
    43.150 USD
    HSY
    HSY
    -7.990
    (-4.47%)
    170.850 USD
    KHC
    KHC
    -0.645
    (-2.03%)
    31.135 USD
    KMB
    KMB
    2.420
    (1.84%)
    134.090 USD
    M
    MKC
    -0.930
    (-1.24%)
    73.980 USD
    N
    NWL
    -0.16000
    (-1.78%)
    8.81000 USD
    PG
    PG
    2.450
    (1.47%)
    169.550 USD
    T
    TUP
    0
    (0%)
    0.000000 USD
    More
News

Title: Castle Biosciences

Sector: Healthcare
Industry: Diagnostics & Research
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.